AI Health & Biotechnology
MIT AI Models Fast-Track New Drug Discovery
Researchers at the Coley Lab deploy FlowER and ShEPhERD to identify drug candidates using generative AI.
A digital visualization of a complex molecular structure and chemical reaction pathways on a high-resolution laboratory monitor, representing MIT's new generative AI drug discovery models.
Photo: Kronos News
Researchers at the Massachusetts Institute of Technology developed AI tools to speed up medicine development. The Coley Lab at MIT released computational models called FlowER and ShEPhERD [1]. These systems analyze millions of chemical compounds to predict reaction pathways and evaluate how drugs interact with proteins [1].
Pharmaceutical companies are already using these tools to find small-molecule drug candidates [1]. Traditional experimental methods take much longer than these new digital simulations [1]. By applying chemical principles to generative AI, the team aims to make drug discovery more efficient [1].
Editorial notes
Transparency note
AI assisted drafting. Human edited and reviewed.
- AI assisted
- Yes
- Human review
- Yes
- Last updated
Risk assessment
The story relies on a single source domain (MIT News), failing the requirement for three independent domains.
Sources
Related stories
View allTopics
About the author
Kronos News Desk covers ai health & biotechnology and editorial analysis for Kronos News.
